Driving AI-Powered Drug Discovery in Partnership with Pfizer (PMWC 2025)

We’re excited to take part in the upcoming 2025 Precision Medicine World Conference in Santa Clara. Janusz Dutkowski, Co-founder & CEO of Data4Cure, will host a session in the AI Models for Drug Discovery & Clinical Research track on February 7 (Day 3, Track 2).

Dr. Dutkowski will join Dr. Paul Rejto (Pfizer) to discuss Knowledge Graphs & Foundation Models for Enhanced Drug Development, highlighting how Data4Cure’s Biomedical Intelligence Cloud enables researchers to move beyond analyzing individual datasets to building a continuously growing, AI-powered knowledge base. The two speakers will also discuss a recently announced partnership between Data4Cure and Pfizer aimed at leveraging advanced analytics and knowledge graph AI to drive innovation in Pfizer’s drug discovery and development programs (see our press release).

At Data4Cure, we focus on integrating large-scale knowledge graphs, multi-omics data, and advanced AI models to accelerate drug discovery and translational research. Our approach helps scientists synthesize information from diverse sources to uncover novel disease mechanisms, identify biomarkers, and refine therapeutic strategies with greater precision.

This year at PMWC 2025, we will share insights on:

●      Building a solid foundation for AI by semantically integrating vast amounts of research and clinical data

●      Combining the latest advancements in LLMs with the structured knowledge encoded in a comprehensive data- and literature-driven knowledge graph

●      Leveraging foundation models for integrating vast amounts of omics data to derive new insights on disease subtypes, drug targets and biomarkers

We look forward to connecting with researchers and industry leaders to explore the next frontier of AI-powered biomedical intelligence. See you at PMWC 2025!